Inactive Instrument
ASCENT INDUSTRIES CORP Stock OTC Markets
Stocks
PGTMF
CA04365B1067
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.27M 2.29M 2.04M 1.9M 1.73M 221M 3.29M 22.98M 8.93M 113M 8.6M 8.42M 362M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 4.77M 3.34M 2.98M 2.78M 2.53M 322M 4.8M 33.57M 13.05M 165M 12.57M 12.3M 529M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
82.94% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 15/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 18/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 15/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 24/06/2020 |
Herb Dhaliwal
CHM | Chairman | 73 | 23/04/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.92% | -.--% | - | - | 2.75M | |
| +0.02% | -3.41% | +36.11% | +115.09% | 1,019B | |
| -1.21% | -6.74% | +34.08% | +62.64% | 617B | |
| +1.12% | +0.54% | +13.62% | +79.94% | 464B | |
| -3.30% | -6.21% | +56.45% | +36.58% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -2.81% | +35.28% | +51.82% | 218B | |
| -0.08% | -4.17% | +28.34% | +93.51% | 179B | |
| Average | +0.21% | -3.54% | +25.47% | +58.17% | 410.8B | |
| Weighted average by Cap. | -0.05% | -3.54% | +28.50% | +70.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 6.95M 6.2M 5.78M 5.26M 670M 9.99M 69.78M 27.13M 342M 26.13M 25.56M 1.1B | 12.12M 8.5M 7.58M 7.06M 6.43M 819M 12.2M 85.25M 33.14M 418M 31.92M 31.23M 1.34B |
| Net income | -2.77M -1.94M -1.73M -1.62M -1.47M -187M -2.79M -19.5M -7.58M -95.63M -7.3M -7.14M -307M | -1.84M -1.29M -1.15M -1.07M -977K -124M -1.85M -12.95M -5.03M -63.5M -4.85M -4.74M -204M |
| Net Debt | 1.37M 963K 859K 801K 729K 92.83M 1.38M 9.67M 3.76M 47.41M 3.62M 3.54M 152M | 1.51M 1.05M 941K 877K 799K 102M 1.52M 10.59M 4.12M 51.91M 3.96M 3.88M 167M |
Employees
-
Sector
Pharmaceuticals
